Mylan N.V. Contracts & Agreements

110 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture among Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., Viatris Inc., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture among Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., Viatris Inc., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture among Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., Viatris Inc., and Citibank, N.A. (Trustee)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
Third Supplemental Indenture among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., and The Bank of New York Mellon, dated November 16, 2020
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
Fourth Supplemental Indenture among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., and The Bank of New York Mellon, as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture among Mylan Inc., Utah Acquisition Sub Inc., Mylan II B.V., Viatris Inc., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture among Mylan Inc., Viatris Inc., and Citibank, N.A. (Trustee)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture to Viatris Inc. Senior Notes Indenture (Guarantee Agreement) – Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., and The Bank of...
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture to 2020 Indenture among Upjohn Finance B.V., Viatris Inc., Mylan Entities, and Citibank, N.A. as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
Amendment No. 3 to Separation and Distribution Agreement between Pfizer Inc., Upjohn Inc., and Mylan N.V.
Plan of Reorganization Agreements
Mylan N.V.
Pharmaceuticals
2020
Separation Agreement and Release between Kenneth S. Parks and Mylan Inc.
Separation Agreements
Mylan N.V.
Pharmaceuticals
PA
2020
Amendment No. 1 to Business Combination Agreement among Pfizer Inc., Upjohn Inc., Mylan N.V., and Affiliates
Merger Agreements
Mylan N.V.
Pharmaceuticals
UT
2020
Mylan N.V. 2003 Long-Term Incentive Plan Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2020
Mylan N.V. 2003 Long-Term Incentive Plan Stock Option Agreement for Board Members
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
2020
Executive Employment Agreement between Mylan N.V., Mylan Inc., and Robert J. Coury (April 2020)
Employment Agreements
Mylan N.V.
Pharmaceuticals
NY
2020
Description of Mylan N.V. Ordinary Shares Registered Under Section 12 of the Exchange Act
Stock Agreements
Mylan N.V.
Pharmaceuticals
2020
2007 Supplemental Health Insurance Plan for Certain Key Employees of Mylan Laboratories Inc.
Compensation Agreements
Mylan N.V.
Pharmaceuticals
2020
Mylan N.V. Severance Plan and Global Guidelines (July 2019)
Severance Agreements
Mylan N.V.
Pharmaceuticals
2019
Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc. dated July 29, 2019
Separation Agreements
Mylan N.V.
Pharmaceuticals
UT
2019
Business Combination Agreement among Pfizer Inc., Upjohn Inc., Utah Acquisition Sub Inc., Mylan N.V., Mylan I B.V., and Mylan II B.V. dated July 29, 2019
Merger Agreements
Mylan N.V.
Pharmaceuticals
UT
2019
Mylan N.V. 2003 Long-Term Incentive Plan Performance-Based Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2019
Mylan N.V. 2003 Long-Term Incentive Plan Stock Option Agreement with Employee
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
2019
Mylan N.V. 2003 Long-Term Incentive Plan Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2019
Supplemental Health Insurance Program for Certain Officers of Mylan Laboratories Inc. (Amended and Restated May 1, 2005)
Compensation Agreements
Mylan N.V.
Pharmaceuticals
2019
Amendment to Executive Employment Agreement between Mylan Inc. and Heather Bresch (November 3, 2018)
Employment Agreements
Mylan N.V.
Pharmaceuticals
2019
Third Amended and Restated Executive Employment Agreement between Mylan Inc. and Heather Bresch
Employment Agreements
Mylan N.V.
Pharmaceuticals
NY
2019
Amendment to Executive Employment Agreement between Mylan Inc. and Rajiv Malik (November 3, 2018)
Employment Agreements
Mylan N.V.
Pharmaceuticals
2019
Third Amended and Restated Executive Employment Agreement between Mylan Inc. and Rajiv Malik
Employment Agreements
Mylan N.V.
Pharmaceuticals
NY
2019
Executive Employment Agreement between Mylan Inc. and Anthony Mauro (Chief Commercial Officer)
Employment Agreements
Mylan N.V.
Pharmaceuticals
PA
2019
Executive Employment Agreement between Mylan Inc. and Kenneth S. Parks (CFO)
Employment Agreements
Mylan N.V.
Pharmaceuticals
PA
2019
Consulting Agreement between Mylan Inc. and Daniel M. Gallagher
Consulting Agreements
Mylan N.V.
Pharmaceuticals
PA
2019
Amendment to Term Credit Agreement among Mylan N.V., Mylan Inc., Goldman Sachs Bank USA, and Lenders (February 22, 2019)
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2019
Indenture for 2.125% Senior Notes Due 2025 between Mylan Inc., Mylan N.V., and Citibank, N.A., London Branch
Indenture Agreements
Mylan N.V.
Pharmaceuticals
PA
2018
Mylan N.V. 2003 Long-Term Incentive Plan Performance-Based Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2018
Mylan N.V. 2003 Long-Term Incentive Plan Performance-Based Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2018
Indenture for Mylan Inc. 4.550% Senior Notes Due 2028 and 5.200% Senior Notes Due 2048 with The Bank of New York Mellon as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
NY
2018
Amendment to Revolving Credit Agreement among Mylan N.V., Bank of America, N.A., and Lenders (November 3, 2017)
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2017
Amendment to Term Credit Agreement among Mylan N.V., Guarantors, Lenders, and Goldman Sachs Bank USA (November 3, 2017)
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2017
Corporate Integrity Agreement Between HHS OIG and Mylan Inc. and Mylan Specialty L.P.
Settlement Agreements
Mylan N.V.
Pharmaceuticals
2017
Indenture for Mylan N.V. Floating Rate Senior Notes Due 2020 with Citibank, N.A., London Branch as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
PA
2017
Amendment to Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan (February 2017)
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
2017
Mylan N.V. 2003 Long-Term Incentive Plan Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2017
Mylan N.V. 2003 Long-Term Incentive Plan Performance-Based Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2017
Waiver Letter Regarding Accelerated Vesting Upon Retirement for Restricted Stock Units (Mylan N.V.)
Waiver Agreements
Mylan N.V.
Pharmaceuticals
2017
Executive Employment Agreement between Mylan Inc. and Daniel M. Gallagher (Chief Legal Officer and Global General Counsel)
Employment Agreements
Mylan N.V.
Pharmaceuticals
PA
2017
Transition and Succession Agreement between Mylan Inc. and Daniel M. Gallagher
Transition Agreements
Mylan N.V.
Pharmaceuticals
2017
Mylan N.V. Performance-Based Restricted Stock Unit Award Agreement for Special Five-Year Incentive Program
Compensation Agreements
Mylan N.V.
Pharmaceuticals
PA
2017
Retirement and Consulting Agreement between Mylan Inc. and John D. Sheehan
Retirement Agreements
Mylan N.V.
Pharmaceuticals
PA
2016
Executive Employment Agreement between Mylan Inc. and Kenneth S. Parks (Chief Financial Officer)
Employment Agreements
Mylan N.V.
Pharmaceuticals
PA
2016
Transition and Succession Agreement between Mylan Inc. and Kenneth S. Parks (June 6, 2016)
Transition Agreements
Mylan N.V.
Pharmaceuticals
2016
Transition and Compensation Letter Agreement between Mylan N.V. and Robert J. Coury (June 3, 2016)
Employment Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Indenture for Mylan N.V. Senior Notes Due 2019, 2021, 2026, and 2046 with The Bank of New York Mellon as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Shareholder Agreement between Mylan N.V. and Stena Sessan Rederi AB (February 10, 2016)
Shareholders Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Shareholder Agreement between Mylan N.V. and Fidim S.r.l. dated February 10, 2016
Shareholders Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Bridge Credit Agreement among Mylan N.V., Guarantors, Deutsche Bank AG Cayman Islands Branch, and Lenders
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Amended and Restated Executive Employment Agreement between Mylan Inc. and Anthony Mauro
Employment Agreements
Mylan N.V.
Pharmaceuticals
PA
2016
Mylan N.V. 2003 Long-Term Incentive Plan Stock Option Agreement with Optionee
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
2016
Mylan N.V. 2003 Long-Term Incentive Plan Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2016
Mylan N.V. 2003 Long-Term Incentive Plan Performance-Based Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2016
Mylan N.V. 2003 Long-Term Incentive Plan Stock Option Agreement with Optionee
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
2016
Mylan N.V. 2003 Long-Term Incentive Plan Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2016
Mylan N.V. 2003 Long-Term Incentive Plan Performance-Based Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Mylan N.V.
Pharmaceuticals
PA
2016
Indenture for Mylan N.V. 3.000% Senior Notes Due 2018 and 3.750% Senior Notes Due 2020 with The Bank of New York Mellon as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Waiver Letter to Transition and Succession Agreement between Mylan Inc. and Employee
Waiver Agreements
Mylan N.V.
Pharmaceuticals
2015
Fourth Supplemental Indenture to 3.750% Cash Convertible Notes Due 2015 – Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Third Supplemental Indenture to 2010 Indenture for 7.875% Senior Notes Due 2020 – Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Second Supplemental Indenture to 3.125% Senior Notes Due 2023 between Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Second Supplemental Indenture to 1.800% and 2.600% Senior Notes between Mylan Inc., Mylan N.V., and The Bank of New York Mellon (March 12, 2015)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Third Supplemental Indenture to November 2013 Indenture among Mylan Inc., Mylan N.V., and The Bank of New York Mellon (March 12, 2015)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Amendment No. 1 to Amended and Restated Executive Employment Agreement between Mylan Inc. and Anthony Mauro
Employment Agreements
Mylan N.V.
Pharmaceuticals
2015
Second Supplemental Indenture to 3.75% Cash Convertible Notes Due 2015 between Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Third Supplemental Indenture to 3.750% Cash Convertible Notes Due 2015 among Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Second Supplemental Indenture to 7.875% Senior Notes Due 2020 between Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
First Supplemental Indenture to 3.125% Senior Notes Due 2023 between Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
First Supplemental Indenture to 1.800% and 2.600% Senior Notes—Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Second Supplemental Indenture and Guarantee Agreement among Mylan Inc., Mylan N.V., and The Bank of New York Mellon (2015)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Amendment No. 4 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Mylan N.V.
Pharmaceuticals
2020
Commercial Paper Dealer Agreement (4(a)(2) Program) among Viatris Inc., Mylan Inc., Mylan II B.V., Utah Acquisition Sub Inc., and Dealer
Financing Agreements
Mylan N.V.
Pharmaceuticals
NY
2020
Asset Purchase Agreement between Aspen Global Incorporated and Mylan Ireland Limited dated September 7, 2020
Purchase Agreements
Mylan N.V.
Pharmaceuticals
2020
Amendment No. 2 to Revolving Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and Bank of America, N.A.
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2020
Amendment No. 2 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Mylan N.V.
Pharmaceuticals
UT
2020
Amendment No. 1 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Mylan N.V.
Pharmaceuticals
2020
Amendment to Revolving Credit Agreement among Mylan Inc., Mylan N.V., Bank of America, N.A., and Lenders (February 22, 2019)
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2019
Revolving Credit Agreement among Mylan Inc., Mylan N.V., Bank of America, N.A., and Lenders (July 27, 2018)
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2018
Commercial Paper Dealer Agreement among Mylan Inc., Mylan N.V., and Dealer
Financing Agreements
Mylan N.V.
Pharmaceuticals
NY
2018
Mylan Inc. Registration Rights Agreement for $1.5 Billion Senior Notes (2028 & 2048)
Registration Rights Agreements
Mylan N.V.
Pharmaceuticals
NY
2018
Settlement Agreement Among United States, Mylan Inc., Mylan Specialty L.P., and Relators Regarding EpiPen Medicaid Rebates
Settlement Agreements
Mylan N.V.
Pharmaceuticals
2017
Commercial Paper Dealer Agreement among Mylan N.V., Mylan Inc., and Dealer
Financing Agreements
Mylan N.V.
Pharmaceuticals
NY
2017
Amendment No. 1 to Amended and Restated Receivables Purchase Agreement among Mylan Pharmaceuticals Inc., Mylan Securitization LLC, Victory Receivables Corporation, PNC Bank, and...
Purchase Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Mylan N.V. Registration Rights Agreement for $6.5 Billion Senior Notes (2019–2046) with Initial Purchasers
Registration Rights Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Amendment No. 3 to Revolving Credit Agreement among Mylan Inc., Mylan N.V., Bank of America, N.A., and Lenders
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Amendment No. 3 to Term Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and Bank of America, N.A.
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Amendment No. 2 to Term Credit Agreement among Mylan Inc., Mylan N.V., PNC Bank, and Lenders
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Irrevocable Undertaking Agreement between Mylan N.V. and Stena Sessan Rederi AB regarding Meda AB Offer
Mylan N.V.
Pharmaceuticals
2016
Irrevocable Undertaking between Mylan N.V. and Fidim S.r.l. regarding Public Offer for Meda AB Shares
Mylan N.V.
Pharmaceuticals
2016
Mylan N.V. Registration Rights Agreement for $1 Billion Senior Notes (2018 & 2020)
Registration Rights Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Term Credit Agreement among Mylan Inc., Mylan N.V., PNC Bank, and Other Lenders (July 15, 2015)
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 2 to Term Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and Bank of America, N.A.
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 2 to Revolving Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and Bank of America, N.A.
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 1 to Term Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and PNC Bank, N.A.
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 2 to Bridge Credit Agreement among Mylan N.V., Lenders, and Goldman Sachs Bank USA
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Additional Credit Extension Amendment to Revolving Credit Agreement among Mylan Inc., Mylan N.V., ING Bank N.V., and Bank of America, N.A.
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 1 to Revolving Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and Bank of America, N.A.
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 1 to Term Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and Bank of America, N.A.
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 1 to Bridge Credit Agreement among Mylan N.V., Lenders, and Goldman Sachs Bank USA
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Bridge Credit Agreement among Mylan N.V., Guarantors, and Goldman Sachs Bank USA, dated April 24, 2015
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Mylan N.V. Underwriting Agreement for Sale of 35,000,000 Ordinary Shares by Selling Shareholders to Underwriters (2015)
Underwriting Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Call Option Agreement between Stichting Preferred Shares Mylan and Mylan N.V. (April 3, 2015)
Mylan N.V.
Pharmaceuticals
2015
Shareholder Agreement among Mylan N.V. and Abbott Shareholders dated February 27, 2015
Shareholders Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Mylan N.V. Indemnification Agreement with Director
Indemnification Agreements
Mylan N.V.
Pharmaceuticals
DE
2015